LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Capillary Zone Electrophoresis Developed for Rapid Determination of Thalassemia

By LabMedica International staff writers
Posted on 10 Jun 2015
Print article
Image: The P/ACE MDQ Capillary Electrophoresis System (Photo courtesy of Beckman Coulter Inc.).
Image: The P/ACE MDQ Capillary Electrophoresis System (Photo courtesy of Beckman Coulter Inc.).
A capillary zone electrophoresis (CZE) method has been developed for human globin determination in the diagnosis of thalassemia and hemoglobin variants as analysis of globin chains is an important aspect of thalassemia diagnostics.

Thalassemia is an inherited autosomal recessive blood disorder characterized by the underproduction of globin chains as a consequence of globin gene defects, resulting in malfunctioning red blood cells and oxygen transport.

Medical scientists at the Southern Medical University (Guangzhou, China) evaluated an assay on blood samples obtained from anticoagulated whole blood from a total of 310 clinical samples consisting of 58 normal, 107 α-thalassemia silent/trait, 42 β-thalassemia carriers and 63 β-thalassemia major and β-thalassemia intermedia (β -TM/TI), and 40 others with various hemoglobinopathies.

Hemoglobin analysis was carried out using the high-performance liquid chromatography (HPLC, Variant II, Bio-Rad Laboratories; Hercules, CA, USA). Capillary zone electrophoresis (CZE) was performed using a P/ACE MDQ Capillary Electrophoresis System (Beckman Coulter Inc.; Fullerton, CA, USA) equipped with a 70 cm × 50 μm uncoated fused-silica capillary at 25 °C.

Distinct globin peaks were resolved in 17 minutes and coefficients of variation (CV) for migration time and areas ranged from 0.37% to 1.69% and 0.46% to 6.71%, respectively. Receiver operating characteristic (ROC) curve analysis of the α/β area ratios gave 100% sensitivity and specificity for indicating β-TI/TM, and 100% sensitivity and 97.4% specificity for Hb H disease. Hemoglobin G-Honolulu (Hb G-Honolulu) and Hb Westmead (Hb WS) were successfully detected using this CZE method.

The authors concluded that they had successfully developed a simple, rapid, high-resolution CZE method for the separation of globin chains using highly acidic buffer and uncoated capillaries. Using this method, α-, β- and γ-chains, and αWS and αG Honolulu  chains were successfully separated within 17 minutes, indicating suitability for routine clinical applications. The migration times and globin chain peak areas were highly reproducible; although not as rapid as existing high-throughput HPLC techniques. This CZE method may provide an attractive complementary and/or confirmatory approach. The study was published in the June 2015 issue of the journal Blood Cells Molecules and Diseases.

Related Links:

Southern Medical University 
Bio-Rad Laboratories  
Beckman Coulter Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: Molecular PCR-grade detection of Lyme bacteria right at the tick bite (Photo courtesy of En Carta Diagnostics)

Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes

Lyme disease, transmitted through tick bites, is a bacteria-caused illness that impacts 1.2 million individuals annually. The standard methods for diagnosing this disease include clinical examinations,... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more